X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

    AstraZeneca Eyes Acquisition To Develop Cell Therapies

    Advanced Instruments All Set To Merge With Nova Biomedical

    Taiho Pharmaceutical Buys Araris Biotech AG For $740 Million

    Oracle Wins the Asia Pacific Biopharma Excellence Awards

    Continuous Manufacturing is Improving Biopharma Production

    AI in Drug Commercialization Market to Grow CAGR 24% by 2032

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

    AstraZeneca Eyes Acquisition To Develop Cell Therapies

    Advanced Instruments All Set To Merge With Nova Biomedical

    Taiho Pharmaceutical Buys Araris Biotech AG For $740 Million

    Oracle Wins the Asia Pacific Biopharma Excellence Awards

    Continuous Manufacturing is Improving Biopharma Production

    AI in Drug Commercialization Market to Grow CAGR 24% by 2032

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Americas

Arctic™ Sperm Cryopreservation Medium introduced by Irvine Scientific

Yuvraj_pawp by Yuvraj_pawp
11th October 2017
in Americas, News

Irvine Scientific, a world leader in the development and manufacture of cell culture media and Assisted Reproductive Technologies (ART), today announced the introduction of Arctic™ Sperm Cryopreservation Medium. This new medium is formulated to improve the post-thaw performance of frozen sperm samples and reduce the cost of sperm cryopreservation.

Increasing numbers of infertility cases are found to be caused by male reproductive problems. Overcoming these is an important factor for successful in vitro fertilization. Sperm cryopreservation is often performed as insurance in case a fresh sample fails, for poor quality semen, and to preserve samples for sperm donation. Arctic Sperm Cryopreservation Medium has an enriched formula high in glycerol that provides effective cryopreservation at a low 3:1 ratio of semen to medium. This minimizes dilution of poor quality samples compared to most commercial sperm cryopreservation media that require a 1:1 ratio. Arctic Sperm Cryopreservation Medium uses a dual buffer system of HEPES and MOPS that maintains a stable environment while on the benchtop. These benefits result in the improved post-thaw performance of sperm.

Andrology and IVF laboratories need to keep the cost of sperm cryopreservation and storage down. Arctic Sperm Cryopreservation Medium requires 60% less medium per application—resulting in significant savings. It also increases the amount of semen stored per cryovial or straw to aid in reducing storage costs.

“We applied the latest knowledge of media formulation to develop a medium that provides the stability required to minimize stress on the specimen during processing,” said Dr. Jessie Ni, Chief Scientific Officer at Irvine Scientific. “Irvine Scientific has been at the forefront of developing products for andrology since 1987, and Arctic Sperm Cryopreservation Medium represents our continued commitment to improving success in the andrology laboratory.”
Arctic Sperm Cryopreservation Medium does not contain test yolk buffer (TYB) and is available in kits of 12 x 5 mL.

For more information visit http://www.irvinesci.com/assisted-reproductive-technology

About Irvine Scientific
Irvine Scientific, a member of JXTG Group, is a worldwide leader in the innovation and manufacture of cell culture media, reagents, and medical devices for researchers and clinicians. The company provides unrivalled service and quality to scientists working in cell therapy and regenerative medicine, assisted reproductive technology and cytogenetics, and industrial cell culture for the large-scale production of biotherapeutics and vaccines. Irvine Scientific adheres to both ISO and FDA regulations and operates dual cGMP manufacturing facilities in California, USA and Tokyo, Japan. The company’s consultative philosophy combined with expertise in cell culture and compliance provides customers with unique capabilities and support. For over 45 years, Irvine Scientific has remained uniquely flexible and focused on media while becoming a strategic global leader in media products and services.

Media contacts
Lori Serles, Irvine Scientific
Phone: 949-261-7800 x145
Email: lserles@irvinesci.com
Lorna Cuddon, Zyme Communications
Phone: +44 (0)7811996942
Email: lorna.cuddon@zymecommunications.com

Tags: America
Previous Post

Antares pharma announces sale of zomajet™ needle-free delivery system to ferring pharmaceuticals

Next Post

Liquid Biopsy Tumor Heterogeneity Test Predicts Resistance to Targeted Therapy In Metastatic Prostate Cancer Patients

Related Posts

DHL Supply Chain
News

DHL Supply Chain comes up with New Pharma Hub in Singapore

19th April 2025
Healthcare Packaging
Asia

Amcor Healthcare Packaging Expansion in Asia Pacific

16th April 2025
Drug Development

Advanced Instruments All Set To Merge With Nova Biomedical

22nd March 2025
Drug Development

Taiho Pharmaceutical Buys Araris Biotech AG For $740 Million

21st March 2025
Clinical Trials

Oracle Wins the Asia Pacific Biopharma Excellence Awards

21st March 2025
Americas

Thermo Fisher to acquire Solventum’s Purification & Filtration business for US$4.1bn

4th March 2025
Next Post

Liquid Biopsy Tumor Heterogeneity Test Predicts Resistance to Targeted Therapy In Metastatic Prostate Cancer Patients

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In